{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T10:24:21Z","timestamp":1777631061646,"version":"3.51.4"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2017,8,14]],"date-time":"2017-08-14T00:00:00Z","timestamp":1502668800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Aging Clin Exp Res"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1007\/s40520-017-0822-8","type":"journal-article","created":{"date-parts":[[2017,8,14]],"date-time":"2017-08-14T10:01:07Z","timestamp":1502704867000},"page":"605-608","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Can we reliably predict the level of anticoagulation after enoxaparin injection in elderly patients with renal failure?"],"prefix":"10.1007","volume":"30","author":[{"given":"Luca","family":"Pellizzari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Facchinetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luigi","family":"Corr\u00e0","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Sepe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Fantin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giorgia","family":"Fontana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mauro","family":"Zamboni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7282-3642","authenticated-orcid":false,"given":"Vincenzo","family":"Di Francesco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,8,14]]},"reference":[{"key":"822_CR1","doi-asserted-by":"crossref","first-page":"141 S","DOI":"10.1378\/chest.08-0689","volume":"133","author":"J Hirsh","year":"2008","unstructured":"Hirsh J, Bauer KA, Donati MB et al (2008) American college of chest physicians. Parenteral anticoagulants: American college of chest physicians evidence-based clinical practice guidelines (8th edition). Chest 133:141 S\u2013159 S","journal-title":"Chest"},{"key":"822_CR2","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/00007691-200406000-00015","volume":"26","author":"JS Hulot","year":"2004","unstructured":"Hulot JS, Vantelon C, Urien S et al (2004) Effect of renal function on the pharmacokinetics of enoxaparin and consequences on dose adjustment. Ther Drug Monit 26:305\u2013310","journal-title":"Ther Drug Monit"},{"key":"822_CR3","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.thromres.2004.10.004","volume":"116","author":"A Bazinet","year":"2005","unstructured":"Bazinet A, Almanric K, Brunet C et al (2005) Dosage of enoxaparin among obese and renal impairment patients. Thromb Res 116:41\u201350","journal-title":"Thromb Res"},{"key":"822_CR4","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/jphp.12333","volume":"67","author":"HS Al-Sallami","year":"2014","unstructured":"Al-Sallami HS, Medlicott NJ (2014) Investigation of an anti-activated factor X (anti-Xa) assay for the quantification of enoxaparin in human plasma. J Pharm Pharmacol 67:209\u2013214","journal-title":"J Pharm Pharmacol"},{"key":"822_CR5","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1111\/j.1532-5415.1989.tb02250.x","volume":"37","author":"PJ Drinka","year":"1989","unstructured":"Drinka PJ, Langer E (1989) The Cockroft\u2013Gault formula. J Am Geriatr Soc 37:820","journal-title":"J Am Geriatr Soc"},{"key":"822_CR6","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s11239-015-1315-2","volume":"41","author":"MA Smythe","year":"2016","unstructured":"Smythe MA, Priziola J, Dobesh PP et al (2016) Guidance for the practical management of the heparin anticoagulants in the treatment of venous thromboembolism. J Thromb Thrombolysis 41:165\u2013186","journal-title":"J Thromb Thrombolysis"},{"key":"822_CR7","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1001\/2013.jamainternmed.369","volume":"172","author":"DD DeCarolis","year":"2012","unstructured":"DeCarolis DD, Thorson JG, Clairmont MA et al (2012) Enoxaparin outcomes in patients with moderate renal impairment. Arch Intern Med 172:1713\u20131718","journal-title":"Arch Intern Med"},{"key":"822_CR8","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1038\/sj.clpt.6100399","volume":"83","author":"MA Barras","year":"2008","unstructured":"Barras MA, Dufful SB, Atherton JJ et al (2008) Individualized compared with conventional dosing of enoxaparin. Clin Pharmacol Ther 83:882\u2013888","journal-title":"Clin Pharmacol Ther"},{"key":"822_CR9","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1365-2125.2004.02253.x","volume":"59","author":"B Green","year":"2005","unstructured":"Green B, Greenwood M, Saltissi D et al (2005) Dosing strategy for enoxaparin in patients with renal impairment presenting with acute coronary syndromes. Br J Clin Pharmacol 59:281\u2013290","journal-title":"Br J Clin Pharmacol"},{"key":"822_CR10","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.ahj.2004.04.015","volume":"148","author":"MW Kruse","year":"2004","unstructured":"Kruse MW, Lee JJ (2004) Retrospective evaluation of a pharmacokinetic program for adjusting enoxaparin in renal impairment. Am Heart J 148:582\u2013589","journal-title":"Am Heart J"},{"key":"822_CR11","doi-asserted-by":"crossref","first-page":"673","DOI":"10.7326\/0003-4819-144-9-200605020-00011","volume":"144","author":"W Lim","year":"2006","unstructured":"Lim W, Dentali F, Eikelboom JW et al (2006) Meta-analysis: low-molecular-weight heparin and bleeding in patients with severe renal insufficiency. Ann Intern Med 144:673\u2013684","journal-title":"Ann Intern Med"},{"key":"822_CR12","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s11239-016-1384-x","volume":"42","author":"GL Sacha","year":"2016","unstructured":"Sacha GL, Greenlee KM, Ketz JM (2016) The use of anti-factor Xa monitoring in a selection of patients receiving enoxaparin at a large academic medical center. J Thromb Thrombolysis 42:479\u2013485","journal-title":"J Thromb Thrombolysis"},{"key":"822_CR13","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1016\/j.thromres.2008.08.005","volume":"123","author":"NP Clark","year":"2008","unstructured":"Clark NP (2008) Low-molecular-weight heparin use in the obese, elderly, and in renal insufficiency. Thromb Res 123:S58\u2013S61","journal-title":"Thromb Res"},{"key":"822_CR14","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.2215\/CJN.06870909","volume":"5","author":"WM Michels","year":"2010","unstructured":"Michels WM, Grootendorst DC, Verduijn M et al (2010) Performance of the Cockcroft\u2013Gault, MDRD, and new CKD-EPI formulas in relation to GFR, age, and body size. Clin J Am Soc Nephrol 5:1003\u20131009","journal-title":"Clin J Am Soc Nephrol"}],"container-title":["Aging Clinical and Experimental Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40520-017-0822-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40520-017-0822-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40520-017-0822-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,5,24]],"date-time":"2018-05-24T03:41:29Z","timestamp":1527133289000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40520-017-0822-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,14]]},"references-count":14,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["822"],"URL":"https:\/\/doi.org\/10.1007\/s40520-017-0822-8","relation":{},"ISSN":["1720-8319"],"issn-type":[{"value":"1720-8319","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,14]]}}}